BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Vodafone
VOD
$36.1B
| $138M | ﹤0.01% |
8,039,980
-1,968,617
| -20% | -$36.9M |
|
2052
Spectrum Brands
SPB
$2.04B
| $138M | ﹤0.01% |
1,618,719
-100,369
| -6% | -$8.85M |
|
|
HAPN
2053
Happen Inc
HAPN
$2.36B
| $138M | ﹤0.01% |
7,587,213
+1,104,320
| +17% | +$17.2M |
|
|
2054
CALL
Wells Fargo
WFC
$266B
| $138M | ﹤0.01% |
+3,036,200
| New | +$136M |
|
2055
Helix Energy Solutions
HLX
$1.36B
| $137M | ﹤0.01% |
24,066,250
-635,668
| -3% | -$3.34M |
|
2056
CALL
Meta Platforms (Facebook)
META
$1.5T
| $137M | ﹤0.01% |
394,600
+172,700
| +78% | +$55.4M |
|
2057
Scansource
SCSC
$1.16B
| $137M | ﹤0.01% |
4,867,732
-21,198
| -0.4% | -$631K |
|
2058
Certara
CERT
$1.27B
| $137M | ﹤0.01% |
4,828,378
+2,182,487
| +82% | +$60.6M |
|
2059
Protagonist Therapeutics
PTGX
$8.51B
| $136M | ﹤0.01% |
3,040,541
+38,912
| +1% | +$1.28M |
|
2060
Unitil
UTL
$963M
| $136M | ﹤0.01% |
2,573,670
+1,229,926
| +92% | +$66.2M |
|
2061
Chord Energy
CHRD
$7.84B
| $136M | ﹤0.01% |
1,352,902
+983,216
| +266% | +$80.9M |
|
|
CLR
2062
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $136M | ﹤0.01% |
3,575,859
-1,396,198
| -28% | -$43.4M |
|
2063
Harmonic Inc
HLIT
$1.28B
| $136M | ﹤0.01% |
15,958,508
-638,070
| -4% | -$4.89M |
|
2064
ICF International
ICFI
$1.52B
| $136M | ﹤0.01% |
1,546,956
-39,477
| -2% | -$3.61M |
|
2065
Photronics
PLAB
$1.85B
| $136M | ﹤0.01% |
10,283,839
-147,188
| -1% | -$1.92M |
|
|
INFN
2066
DELISTED
Infinera Corporation Common Stock
INFN
| $136M | ﹤0.01% |
13,287,160
-794,224
| -6% | -$7.7M |
|
|
ZUO
2067
DELISTED
Zuora, Inc.
ZUO
| $135M | ﹤0.01% |
7,847,621
-409,989
| -5% | -$6.55M |
|
2068
Innoviva
INVA
$1.53B
| $135M | ﹤0.01% |
10,079,627
-1,269,789
| -11% | -$15.9M |
|
|
PRMW
2069
DELISTED
Primo Water Corporation
PRMW
| $135M | ﹤0.01% |
8,072,598
-206,729
| -2% | -$3.5M |
|
|
AVTA
2070
DELISTED
Avantax, Inc. Common Stock
AVTA
| $135M | ﹤0.01% |
7,795,606
-149,364
| -2% | -$2.45M |
|
|
DCPH
2071
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $135M | ﹤0.01% |
3,681,213
+196,210
| +6% | +$7.6M |
|
2072
Bionano Genomics
BNGO
$12.7M
| $134M | ﹤0.01% |
30,555
+24,852
| +436% | +$98.1M |
|
2073
Collegium Pharmaceutical
COLL
$1.15B
| $134M | ﹤0.01% |
5,666,627
-219,909
| -4% | -$5.08M |
|
2074
Madison Square Garden
MSGS
$9.27B
| $134M | ﹤0.01% |
775,364
-51,169
| -6% | -$9.25M |
|
2075
Monarch Casino & Resort
MCRI
$2.24B
| $134M | ﹤0.01% |
2,019,856
-64,794
| -3% | -$4.47M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.